Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience
2019 ◽
Vol 228
(4)
◽
pp. 644-649
◽
Keyword(s):
2013 ◽
Vol 61
(S 01)
◽
2014 ◽
Vol 62
(S 01)
◽